(Q40397058)

20 September 2017

1 reference

title

Current and potential treatment of tuberculosis (English)

1 reference

20 September 2017

1 reference

S Houston

1

1 reference

PubMed ID

7530627

20 September 2017

A Fanning

series ordinal

2

1 reference

20 September 2017

1 November 1994

1 reference

20 September 2017

20

1 reference

inferred from page(s)

published in

Drugs

1 reference

20 September 2017

48

1 reference

20 September 2017

689-708

1 reference

20 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199448050-00004

20 September 2017

0 references

cites work

Tuberculous meningitis. Short course of chemotherapy

1 reference

12 December 2020

Risk for Developing Tuberculosis among Anergic Patients Infected with HIV

1 reference

12 December 2020

Mycobacteria and the new quinolones

1 reference

12 December 2020

Estimates of future global tuberculosis morbidity and mortality

1 reference

12 December 2020

Six-months versus nine-months chemotherapy for tuberculosis of lymph nodes: preliminary results. British Thoracic Society Research Committee

1 reference

12 December 2020

Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality

1 reference

12 December 2020

Tuberculosis and pregnancy

1 reference

12 December 2020

Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis

1 reference

12 December 2020

Treatment of tuberculosis during pregnancy

1 reference

12 December 2020

The surgery for pulmonary tuberculosis

1 reference

12 December 2020

Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network

1 reference

12 December 2020

Cost savings from alternative treatments for tuberculosis

1 reference

12 December 2020

Comment: intravenous streptomycin

1 reference

12 December 2020

Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis

1 reference

12 December 2020

Controlled trial of short-course regimens of chemotherapy in the ambulatory treatment of spinal tuberculosis. Results at three years of a study in Korea. Twelfth report of the Medical Research Council Working Party on Tuberculosis of the Spine

1 reference

12 December 2020

A controlled clinical trial of the role of thiacetazone-containing regimens in the treatment of pulmonary tuberculosis in Singapore: second report

1 reference

12 December 2020

Ten years of the National Tuberculosis/Leprosy Programme in Tanzania

1 reference

12 December 2020

Drug resistance of Mycobacterium tuberculosis in Korea

1 reference

12 December 2020

Ethambutol: a review with special reference to ocular toxicity

1 reference

12 December 2020

STREPTOMYCIN treatment of pulmonary tuberculosis

1 reference

12 December 2020

The acquired immune deficiency syndrome: with special reference to tuberculosis

1 reference

12 December 2020

Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results

1 reference

12 December 2020

Pott's paraplegia: an account of the treatment of 89 consecutive patients

1 reference

12 December 2020

Shortest possible acceptable effective chemotherapy in ambulatory patients with pulmonary tuberculosis. Part II. Results during the 24 months after the end of chemotherapy

1 reference

12 December 2020

Corticosteroids as an adjuvant to the chemotherapy of tuberculous meningitis

1 reference

12 December 2020

Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council

1 reference

12 December 2020

An Address on Bacteriological Research

1 reference

12 December 2020

Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.

1 reference

12 December 2020

Tuberculosis: a six-month cure

1 reference

12 December 2020

Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement.

1 reference

12 December 2020

Current chemotherapy for tuberculosis in children

1 reference

12 December 2020

Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS.

1 reference

12 December 2020

Tuberculosis in Kenya: follow-up of the second (1974) national sampling survey and a comparison with the follow-up data from the first (1964) national sampling survey. An East African and British Medical Research Council co-operative investigation

1 reference

12 December 2020

Rifabutin prophylaxis against Mycobacterium avium complex infection

1 reference

12 December 2020

Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies

1 reference

12 December 2020

Controlled chemoprophylaxis trials in tuberculosis. A general review

1 reference

12 December 2020

Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET).

1 reference

12 December 2020

Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin

1 reference

12 December 2020

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

1 reference

12 December 2020

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

1 reference

12 December 2020

Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.

1 reference

12 December 2020

The outcome of chemoprophylaxis on tuberculosis prevention in the Canadian Plains Indian

1 reference

12 December 2020

A 10-year assessment of controlled trials of inpatient and outpatient treatment and of plaster-of-Paris jackets for tuberculosis of the spine in children on standard chemotherapy. Studies in Masan and Pusan, Korea. Ninth report of the Medical Researc

1 reference

12 December 2020

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

1 reference

12 December 2020

The association of the risk of tuberculous infection with age

1 reference

12 December 2020

Bacteriology of osteoarticular tuberculosis under chemotherapy

1 reference

12 December 2020

Relapse of tuberculosis in a patient with the acquired immunodeficiency syndrome despite 12 months of antituberculous therapy and continuation of isoniazid

1 reference

12 December 2020

American Academy of Pediatrics Committee on Infectious Diseases: Chemotherapy for tuberculosis in infants and children

1 reference

12 December 2020

Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis

1 reference

12 December 2020

The ambulant treatment of spinal tuberculosis

1 reference

12 December 2020

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

1 reference

12 December 2020

Failure of "optimal" four-drug short-course tuberculosis chemotherapy in a compliant patient with human immunodeficiency virus

1 reference

12 December 2020

Evolution of case-finding and treatment of tuberculosis over the last 3 years following the introduction of short-course chemotherapy of 8 months duration in Benin.

1 reference

12 December 2020

Medicine: The Public Good and One's Own

1 reference

12 December 2020

Aspects of tuberculosis in Africa. 1. Tuberculosis in Africa in the AIDS era--the role of chemoprophylaxis

1 reference

12 December 2020

Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania

1 reference

12 December 2020

Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme.

1 reference

12 December 2020

Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial

1 reference

12 December 2020

Patient compliance. Are we wasting our time and don't know it?

1 reference

12 December 2020

Preventive treatment for tuberculosis control in developing countries. The case for preventive chemotherapy

1 reference

12 December 2020

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

1 reference

12 December 2020

Tuberculosis and pregnancy. Five- to ten-year review of 215 patients in their fertile age

1 reference

12 December 2020

HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention

1 reference

12 December 2020

Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli

1 reference

12 December 2020

When tuberculosis treatment fails. A social behavioral account of patient adherence

1 reference

12 December 2020

An international co-operative investigation into thiacetazone (thioacetazone) side-effects.

1 reference

12 December 2020

1 reference

12 December 2020

A study of two twice-weekly and a once-weekly continuation regimen of tuberculosis chemotherapy, including a comparison of two durations of treatment 2. Second report: The results at 36 months

1 reference

12 December 2020

Treatment of tuberculous meningitis with 6-month course of chemotherapy

1 reference

12 December 2020

Tuberculosis in Eskimos

1 reference

12 December 2020

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

1 reference

12 December 2020

Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis

1 reference

12 December 2020

Six-month combination chemotherapy for cervical tuberculous lymphadenitis

1 reference

12 December 2020

Dexamethasone in tuberculous meningitis. Relationship of cerebrospinal fluid effects to therapeutic efficacy

1 reference

12 December 2020

Philip Ellman lecture. The modern management and therapy of pulmonary tuberculosis

1 reference

12 December 2020

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

1 reference

12 December 2020

The Tuberculosis Manyatta Project for Kenyan nomads

1 reference

12 December 2020

Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study

1 reference

12 December 2020

Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study

1 reference

12 December 2020

A controlled trial of anterior spinal fusion and débridement in the surgical management of tuberculosis of the spine in patients on standard chemotherapy: a study in two centres in South Africa. Seventh Report of the Medical Research Council Working

1 reference

12 December 2020

A double-blind controlled trial of chemoprophylaxis against tuberculosis in patients with silicosis in Hong Kong

1 reference

12 December 2020

Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report. Second East African/British Medical Research Council Study

1 reference

12 December 2020

New concepts for the control of tuberculosis in the twenty first century

1 reference

12 December 2020

A second international cooperative investigation into tioacetazone side effects

1 reference

12 December 2020

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice

1 reference

12 December 2020

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

1 reference

12 December 2020

The Malawi National Tuberculosis Programme.

1 reference

12 December 2020

The synergistic effects of gamma interferon and clofazimine on phagocyte function: restoration of inhibition due to a 25 kilodalton fraction from Mycobacterium tuberculosis.

1 reference

12 December 2020

Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis

1 reference

12 December 2020

Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.

1 reference

12 December 2020

Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council

1 reference

12 December 2020

Perinatally acquired neonatal tuberculosis: report of two cases

1 reference

12 December 2020

Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei.

1 reference

12 December 2020

Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African/British Medical Research Council Study

1 reference

12 December 2020

Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis

1 reference

12 December 2020

Short-course chemotherapy for extrapulmonary tuberculosis. Nine years' experience

1 reference

12 December 2020

New experimental regimens for preventive therapy of tuberculosis

1 reference

12 December 2020

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis

1 reference

12 December 2020

Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations.

1 reference

12 December 2020

Pregnancy-associated depression of cell-mediated immunity.

1 reference

12 December 2020

Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months

1 reference

12 December 2020

Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland

1 reference

12 December 2020

A 10-year assessment of a controlled trial comparing debridement and anterior spinal fusion in the management of tuberculosis of the spine in patients on standard chemotherapy in Hong Kong. Eighth Report of the Medical Research Council Working Party

1 reference

12 December 2020

The association of tuberculosis and HIV infection in Harare, Zimbabwe

1 reference

12 December 2020

Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis

1 reference

12 December 2020

Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council

1 reference

12 December 2020

Levamisole as an adjunct in the treatment of pulmonary tuberculosis

1 reference

12 December 2020

Short course chemotherapy for tuberculous lymphadenitis in children

1 reference

12 December 2020

Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--fifth investigation. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and Briti

1 reference

12 December 2020

Beyond four drugs. Public health policy and the treatment of the individual patient with tuberculosis

1 reference

12 December 2020

Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei

1 reference

12 December 2020

Pott's paraplegia: a clinical review of operative and conservative treatment in 63 adults and children

1 reference

12 December 2020

Corticosteroids and tuberculosis: risks and use as adjunct therapy

1 reference

12 December 2020

The treatment of tuberculous meningitis

1 reference

12 December 2020

Current practices in mycobacteriology: results of a survey of state public health laboratories

1 reference

12 December 2020

Dexamethasone adjunctive treatment for tuberculous meningitis

1 reference

12 December 2020

Update on rifampin drug interactions

1 reference

12 December 2020

Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study

1 reference

12 December 2020

Study of a fully supervised programme of chemotherapy for pulmonary tuberculosis given once weekly in the continuation phase in the rural areas of Hong Kong

1 reference

12 December 2020

Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries

1 reference

12 December 2020

Tuberculosis in the 1990s

1 reference

12 December 2020

Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis.

1 reference

12 December 2020

A controlled trial of 2-month, 3-month, and 12-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 60 months

1 reference

12 December 2020

Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis

1 reference

12 December 2020

Mortality from tuberculous meningitis reduced by steroid therapy

1 reference

12 December 2020

Tuberculosis in developing countries: burden, intervention and cost

1 reference

12 December 2020

Tuberculosis of the spine: a review

1 reference

12 December 2020

High-compliance tuberculosis treatment programme in a rural community

1 reference

12 December 2020

Management of persons exposed to multidrug-resistant tuberculosis

1 reference

12 December 2020

Directly observed treatment of tuberculosis. We can't afford not to try it

1 reference

12 December 2020

A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association

1 reference

12 December 2020

A controlled trial of débridement and ambulatory treatment in the management of tuberculosis of the spine in patients on standard chemotherapy. A study in Bulawayo, Rhodesia

1 reference

12 December 2020

Ten-year experience with artificial pneumoperitoneum for end-stage, drug-resistant pulmonary tuberculosis.

1 reference

12 December 2020

Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet

1 reference

12 December 2020

Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association

1 reference

12 December 2020

EFFECT of streptomycin upon pulmonary tuberculosis; preliminary report of a cooperative study of 223 patients by the Army, Navy and Veterans Administration

1 reference

12 December 2020

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

1 reference

12 December 2020

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

12 December 2020

Thioacetazone--a review

1 reference

12 December 2020

Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs

1 reference

12 December 2020

Pharmacokinetic drug interactions with rifampicin

1 reference

12 December 2020

Evaluation of the results of short-course chemotherapy in Mozambique, 1985-1987

1 reference

12 December 2020

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

12 December 2020

Tuberculous spondylitis. A report of six cases and a review of the literature

1 reference

12 December 2020

The influence of HIV status on single and multiple drug reactions to antituberculous therapy in Africa

1 reference

12 December 2020

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

12 December 2020

10.2165/00003495-199448050-00004

Identifiers

DOI

1 reference

PubMed ID

7530627

Dimensions Publication ID

20 September 2017

0 references

1 reference

PubMed ID

7530627